News
Noticia en Expansión ‘Start up’ que pasan del laboratorio a la empresa
Viva in Vitro, ‘spin off’ del Hospital Clínico Universitario Virgen de la Arrixaca, la Universidad de Murcia y el instituto
Joaquín Gómez Moya: “When innovation is based on science, it is more likely to bring benefits to society”
Viva In Vitro Diagnostics CEO considers it essential to create an association of biotechnology companies in the Region.
Murcia, second fastest growing Spanish region in biotechnological R&D
Evolution. Viva In Vitro is the first technology-based company (EBT) of the Murcian Institute of Biosanitary Research Virgen de la
Viva in vitro, the company that helps fight sepsis
The beginnings of the company Viva in vitro founders, Joaquín Gómez Moya and Prof. Pablo Pelegrín, started collaborating professionally in
Reducing sepsis mortality: the company Viva In Vitro Diagnostics, promoted by Vincle Capital, is getting one step closer to its goal
Sepsis is the leading cause of hospital mortality as it causes around eleven million deaths a year. It also implies
Investors in Viva In Vitro
Today we received the visit of private investors to know the first spinoff of the Murcian Institute of Bio-health Research
Hi!
Welcome to our news page. After years of work and dedication to give this project a corporate shape, Pablo Pelegrín,
Dr. Pablo Pelegrín received INFO’s recognition for his contribution to the Knowledge Economy
During the Somos Equipo event, regional president Fernando López-Miras recognized the leaders of the regional economic transformation towards a Knowledge
